Neurosense Therapeutics Ltd (NRSN)

Neurosense Therapeutics Ltd recorded insider activity on June 16, 2026. Chief Executive Officer Alon Ben-Noon and Chief Financial Officer Or Eisenberg each purchased 250,000 shares, totaling 200,000 dollars per individual. These transactions represent the most recent documented buying interest within the firm, occurring over three months ago.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: NRSN Exchange: NAS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Neurosense Therapeutics Ltd

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Eisenberg Or Chief Financial Officer Officer

Transaction date 16 Jun 2026

Purchase

Price

424.69

Quantity 67,984 -42.2%

Value US$358,141

Comments Filing

Ben-Noon Alon Chief Executive Officer Officer

Transaction date 16 Jun 2026

Purchase

Price

185.21

Quantity 93,481 -14.5%

Value US$4,708,348

Comments Filing

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-06-17	2026-06-16	B Purchase	Eisenberg Or Chief Financial Officer Officer	67,984 -42.2% 424.69 US$358,141	67,984 -42.2%	424.69	US$358,141
2026-06-17	2026-06-16	B Purchase	Ben-Noon Alon Chief Executive Officer Officer	93,481 -14.5% 185.21 US$4,708,348	93,481 -14.5%	185.21	US$4,708,348